Вестник Ассоциации пульмонологов Центральной Азии 13-jild 8-son (2025) · 21-26-betlar

COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY

Mullokulov J.J., Akhmedov Kh.S.

Manbada oʻqish PDF

Annotatsiya

Reactive arthritis (ReA) is a post-infectious spondyloarthritis characterized by arthritis, enthesitis, and extra-articular features. Conventional treatments such as sulfasalazine (SSZ) show modest benefit, while TNF-α inhibitors are effective but limited by cost and accessibility. Baricitinib, a JAK1/2 inhibitor, offers a novel oral therapeutic strategy, though evidence in ReA is scarce.

reactive arthritis, baricitinib, adalimumab, DAREA, BASDAI.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.

Iqtibos olish

APA 7 
Mullokulov J.J., Akhmedov Kh.S. (2025). COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY. Вестник Ассоциации пульмонологов Центральной Азии, 13(8), 21-26.
GOST R 7.0.5 
Mullokulov J.J., Akhmedov Kh.S. COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY // Вестник Ассоциации пульмонологов Центральной Азии. 2025. Т. 13. № 8. С. 21-26.
BibTeX 
@article{kh.s.2025,
  author  = {Mullokulov J.J., Akhmedov Kh.S.},
  title   = {COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY},
  journal = {Вестник Ассоциации пульмонологов Центральной Азии},
  year    = {2025},
  volume  = {13},
  number  = {8},
  pages   = {21-26}
}
RIS 
TY  - JOUR
AU  - Mullokulov J.J., Akhmedov Kh.S.
TI  - COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB PLUS SULFASALAZINE VERSUS TNF-Α INHIBITORS AND SULFASALAZINE MONOTHERAPY IN REACTIVE ARTHRITIS: A 12-MONTH RANDOMIZED STUDY
JO  - Вестник Ассоциации пульмонологов Центральной Азии
PY  - 2025
VL  - 13
IS  - 8
SP  - 21
EP  - 26
ER  -